Infalin Duo

Ciprofloxacin and Fluocinolone Acetonide, the active ingredients in Infalin Duo, are a fluoroquinolone antibiotic and a corticosteroid presented as ear drops for auricular use. They treat bacterial external ear infections and reduce associated inflammation in patients of all ages. GNH USA supplies Infalin Duo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Infalin Duo is indicated for bacterial and inflammatory conditions of the external ear. - Otitis externa: eradicates susceptible bacteria and relieves pain and swelling. - External ear infection: controls infection while decreasing local inflammation. - Bacterial ear canal dermatitis: treats infection and improves skin condition.

Infalin Duo may cause local and systemic reactions.

Common Side Effects: - Ear itching or mild irritation. - Temporary burning sensation after instillation. - Mild ear discharge. - Redness of the external ear canal. - Slight hearing muffling that resolves quickly.

Serious or Rare Side Effects: - Persistent ototoxicity or hearing loss. - Severe allergic reaction (e.g., angio‑edema, anaphylaxis). - Contact dermatitis with blistering. - Secondary fungal infection of the ear. - Vision changes if medication enters the eye.

Before using Infalin Duo, consider the following precautions. - Allergy assessment: avoid if known hypersensitivity to fluoroquinolones, corticosteroids, or any component. - Ear perforation: use with caution; monitor for increased pain or discharge. - Pediatric use: limit to children when prescribed, as safety data are limited. - Pregnancy and lactation: discuss risks with a healthcare professional before use. - Concomitant ototoxic drugs: monitor auditory function if used together. - Store at below 25°C: keep in original container, protect from moisture and direct sunlight.

Infalin Duo can interact with other medicines applied to the ear or systemic agents.

Major Interactions (Avoid): - Systemic fluoroquinolones: increased risk of tendon rupture and QT prolongation. - Systemic corticosteroids: additive immunosuppression may heighten infection risk.

Moderate Interactions (Monitor Closely): - Topical otic preparations containing aminoglycosides: potential ototoxic synergy. - Non‑steroidal anti‑inflammatory drugs (NSAIDs): may enhance fluoroquinolone‑related CNS effects. - Antacids or supplements with divalent cations: can reduce ciprofloxacin absorption if systemic exposure occurs.